ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Internal Medicine

Top Internal Medicine Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN CAMPBELL M.D.

Internal Medicine

44,168

$2.97M

1464
1039 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $63

LEONARD ELLISON MD

Internal Medicine

41,205

$2.72M

1149
686 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

39%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $63

JEROME WILBORN M.D.

Internal Medicine

40,448

$1.96M

1255
1159 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $63

BRUCE JOHNSON D.O.

Internal Medicine

39,253

$2.29M

1143
849 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

IYAD ALOSACHIE M.D.

Internal Medicine

34,178

$1.88M

828
635 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $63

EMIL SITTO M.D.

Internal Medicine

32,633

$1.53M

711
607 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $63

PRAKASH SARVEPALLI M.D.

Internal Medicine

31,435

$2.04M

741
582 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $63

STEVEN HAMBERG MD

Internal Medicine

31,156

$1.4M

708
653 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $63

BABAR SANAULLAH MD

Internal Medicine

30,521

$1.68M

855
597 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $63

MACIEJ SOLAREWICZ MD

Internal Medicine

30,266

$1.74M

803
623 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

LAINA FEINSTEIN MD

Internal Medicine

30,094

$2.26M

555
512 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $63

MOUSA MOHAMED M.D.

Internal Medicine

29,431

$1.47M

1000
434 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $63

MUSIB GAPPY MD

Internal Medicine

29,296

$1.41M

886
676 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $63

YOUSIF MANSOUR M.D.

Internal Medicine

28,177

$2.3M

489
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $63

ATHAR SIDDIQUI M.D.

Internal Medicine

26,525

$1.52M

877
380 are 65+

28%
patients receiving schedule two controlled substances

Avg: 4%

42%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $63

BASEL BRIKHO MD

Internal Medicine

24,966

$1.18M

458
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $63

PRITI BHARDWAJ MD

Internal Medicine

24,766

$1.45M

597
187 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

59%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $63

ALPHONSO BERRY M.D.

Internal Medicine

21,916

$1.2M

660
386 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

32%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $63

WASSIM YOUNES MD

Internal Medicine

21,181

$1.38M

639
501 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $63

KENNETH CHUN MD

Internal Medicine

21,179

$1.92M

768
308 are 65+

43%
patients receiving schedule two controlled substances

Avg: 4%

48%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$91
Average prescription price

Avg: $63

CLINTON HARRIS M.D.

Internal Medicine

20,574

$1.07M

468
457 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $63

AAMER BHURGRI INTERNAL MEDICINE

Internal Medicine

20,201

$985K

540
249 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $63

ALEX-ABBEY AKIN-WUMI MD

Internal Medicine

19,962

$1.27M

611
255 are 65+

47%
patients receiving schedule two controlled substances

Avg: 4%

45%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $63

BHIKAM MEHTA M.D.

Internal Medicine

19,550

$1.11M

322
294 are 65+

25%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $63

PAUL GIETZEN M.D.

Internal Medicine

19,254

$1.09M

753
713 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank